PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: sequestration
Budget Cutters Propose Big Hits on Pharma
By Jill Wechsler, Washington Correspondent.
The Obama administration’s budget plan for fiscal year 2014 apparently assumes that the pharmaceutical industry can support Medicare and other health programs through changes in drug coverage and payments. It also relies on industry fees to keep the Food and Drug Administration up and running. Meanwhile, FDA and other public health [...]
Posted in Guest Blog, Op-Ed, healthcare Also tagged buget, Cuts, FDA, healthcare reform, NIH, Obamacare, pay-for-delay Leave a comment
Sequestration: How Big a Hit for FDA, Research and Pharma?
The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Posted in FDA, Legal, R&D, healthcare, leadership Also tagged Capitol Hill, CDC, NIH, Politics, Sequestration Act, United States Congress, White House Leave a comment
Ethics in Drug Innovation: The First Hurdle is Trust
By Ansis Helmanis
Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry. This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel [...]
Posted in Europe, Events, FDA, Global, Guest Blog, Market Access, Patient Communication, Regulatory, healthcare, leadership, pricing Also tagged CMS, Elie Wiesel, EMA, FDA, Guido Rasi, Margaret Hamburg, Prix Galien, reimbursement Leave a comment
Will Congress Provide Sequester "Flexibility" for User Fees?